Global Low Molecular Weight Heparin Market Research Report 2017

Publisher Name :
Date: 10-Nov-2017
No. of pages: 107
Inquire Before Buying

The global production of low molecular weight heparin increases from 12467 Kg in 2012 to 16852 Kg in 2016, at a CAGR of more than 7.82%. In 2016, in term of volume, the global Low molecular weight heparin market is led by china, capturing about 49.57% of global low molecular weight heparin production. In term of revenue, USA is the second's largest market with the share of 30.49%.

This report studies Low Molecular Weight Heparin in Global market, especially in USA, Europe, China and Asia (Ex. China), focuses on top manufacturers in global market, with capacity, production, price, revenue and market share for each manufacturer, covering

Aspen

Sanofi-aventis

Pfizer

Opocrin

CSBIO

Dongying Tiandong Pharmaceutical

Changzhou Qianhong Bio-pharma

Techdow

Yantai Dongcheng Pharmaceutical Group

Market Segment by Regions, this report splits Global into several key Regions, with production, consumption, revenue, market share and growth rate of Low Molecular Weight Heparin in these regions, from 2012 to 2023 (forecast), like

USA

China

Europe

Asia (Ex. China)

Split by Product Types, with production, revenue, price, market share and growth rate of each type, can be divided into

Enoxaparin

Dalteparin

Tinzaparin

Fraxiparine

Split by applications, this report focuses on consumption, market share and growth rate of Low Molecular Weight Heparin in each application, can be divided into

Treatment of Venous Thromboembolism

Complications of Pregnancy

Cardioversion of Atrial Fibrillation/Flutter

Others

Global Low Molecular Weight Heparin Market Research Report 2017

Table of Contents
1 Low Molecular Weight Heparin Market Overview 1
1.1 Product Overview and Scope of Low Molecular Weight Heparin 1
1.2 Low Molecular Weight Heparin Segment by Types 2
1.2.1 Global Production Market Share of Low Molecular Weight Heparin by Types in 2016 2
1.2.2 Enoxaparin 2
1.2.3 Dalteparin 2
1.2.4 Tinzaparin 3
1.2.5 Fraxiparine 3
1.3 Low Molecular Weight Heparin Segment by Applications 3
1.3.1 Low Molecular Weight Heparin Consumption Market Share by Applications in 2016 3
1.3.2 Treatment of Venous Thromboembolism 4
1.3.3 Complications of Pregnancy 4
1.3.4 Cardioversion of Atrial Fibrillation/Flutter 4
1.4 Low Molecular Weight Heparin Market by Regions 5
1.4.1 USA Status and Prospect (2012-2023) 5
1.4.2 China Status and Prospect (2012-2023) 6
1.4.3 Europe Status and Prospect (2012-2023) 7
1.5 Global Market Size (Value) of Low Molecular Weight Heparin (2012-2023) 8
2 Global Low Molecular Weight Heparin Market Competition by Manufacturers 9
2.1 Global Low Molecular Weight Heparin Capacity, Production and Share by Manufacturers (2012-2017) 9
2.2 Global Low Molecular Weight Heparin Revenue and Share by Manufacturers (2012-2017) 14
2.3 Global Low Molecular Weight Heparin Average Price by Manufacturers (2012-2017) 17
2.4 Manufacturers Low Molecular Weight Heparin Manufacturing Base Distribution and Sales Area 20
2.5 Low Molecular Weight Heparin Market Competitive Situation and Trends 21
2.5.1 Low Molecular Weight Heparin Market Share (Revenue) of Top 3 and Top 5 Manufacturers 21
2.5.2 Mergers & Acquisitions, Expansion 22
3 Global Low Molecular Weight Heparin Capacity, Production, Revenue (Value) by Regions (2012-2017E) 24
3.1 Global Low Molecular Weight Heparin Capacity and Market Share by Regions (2012-2017E) 24
3.2 Global Low Molecular Weight Heparin Production and Market Share by Regions (2012-2017E) 26
3.3 Global Low Molecular Weight Heparin Revenue (Value) and Market Share by Regions (2012-2017E) 28
3.4 Global Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012-2017E) 29
3.5 USA Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012-2017E) 30
3.6 Europe Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012-2017E) 30
3.7 China Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012-2017E) 31
4 Global Low Molecular Weight Heparin Supply (Production), Consumption, Export, Import by Regions (2012-2017E) 32
4.1 Global Low Molecular Weight Heparin Consumption by Regions (2012-2017E) 32
4.2 USA Low Molecular Weight Heparin Production, Consumption, Export, Import by Regions (2012-2017E) 34
4.3 Europe Low Molecular Weight Heparin Production, Consumption, Export, Import by Regions (2012-2017E) 34
4.4 China Low Molecular Weight Heparin Production, Consumption, Export, Import by Regions (2012-2017E) 34
4.5 Asia (Ex. China) Low Molecular Weight Heparin Production, Consumption, Export, Import by Regions (2012-2017E) 35
5 Global Low Molecular Weight Heparin Production, Revenue (Value), Price Trend by Types 36
5.1 Global Low Molecular Weight Heparin Production and Market Share by Types (2012-2017E) 36
5.2 Global Low Molecular Weight Heparin Revenue and Market Share by Types (2012-2017E) 38
5.3 Global Low Molecular Weight Heparin Price by Type (2012-2017E) 40
5.4 Global Low Molecular Weight Heparin Production Growth by Type (2012-2017E) 40
6 Global Low Molecular Weight Heparin Market Analysis by Applications 41
6.1 Global Low Molecular Weight Heparin Consumption and Market Share by Applications (2012-2017E) 41
6.2 Global Low Molecular Weight Heparin Consumption Growth Rate by Applications (2012-2017E) 43
7 Global Low Molecular Weight Heparin Manufacturers Profiles/Analysis 44
7.1 Aspen 44
7.1.1 Company Profile 44
7.1.2 Low Molecular Weight Heparin Product Information 44
7.1.3 Aspen Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 44
7.1.4 Contact Information 45
7.2 Sanofi-aventis 46
7.2.1 Company Profile 46
7.2.2 Low Molecular Weight Heparin Product Information 46
7.2.3 Sanofi-aventis Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 47
7.2.4 Contact Information 47
7.3 Pfizer 48
7.3.1 Company Profile 48
7.3.2 Low Molecular Weight Heparin Product Information 48
7.3.3 Pfizer Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 48
7.3.4 Contact Information 49
7.4 Opocrin 50
7.4.1 Company Profile 50
7.4.2 Low Molecular Weight Heparin Product Information 50
7.4.3 Opocrin Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 50
7.4.4 Contact Information 51
7.5 CSBIO 51
7.5.1 Company Profile 51
7.5.2 Low Molecular Weight Heparin Product Information 52
7.5.3 CSBIO Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 53
7.5.4 Contact Information 53
7.6 Dongying Tiandong Pharmaceutical 54
7.6.1 Company Profile 54
7.6.2 Low Molecular Weight Heparin Product Information 54
7.6.3 Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 55
7.6.4 Contact Information 56
7.7 Changzhou Qianhong Bio-pharma 56
7.7.1 Company Profile 56
7.7.2 Low Molecular Weight Heparin Product Information 57
7.7.3 Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 57
7.7.4 Contact Information 58
7.8 Techdow 58
7.8.1 Company Profile 58
7.8.2 Low Molecular Weight Heparin Product Information 59
7.8.3 Techdow Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 60
7.8.4 Contact Information 61
7.9 Yantai Dongcheng Pharmaceutical Group 61
7.9.1 Company Profile 61
7.9.2 Low Molecular Weight Heparin Product Information 62
7.9.3 Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 62
7.9.4 Contact Information 63
8 Low Molecular Weight Heparin Manufacturing Cost Analysis 64
8.1 Low Molecular Weight Heparin Key Raw Materials Analysis 64
8.1.1 Key Raw Materials 64
8.1.2 Key Suppliers of Raw Materials 64
8.2 Proportion of Manufacturing Cost Structure 65
8.2.1 Raw Materials 65
8.2.2 Labor Cost 65
8.2.3 Manufacturing Expenses 69
8.3 Manufacturing Process Analysis of Low Molecular Weight Heparin 70
9 Industrial Chain, Sourcing Strategy and Downstream Buyers 71
9.1 Low Molecular Weight Heparin Industrial Chain Analysis 71
9.2 Upstream Raw Materials Sourcing 71
9.3 Raw Materials Sources of Low Molecular Weight Heparin Major Manufacturers in 2016 72
9.4 Downstream Buyers 72
10 Marketing Strategy Analysis, Distributors/Traders 74
10.1 Marketing Channel 74
10.1.1 Direct Marketing 74
10.1.2 Indirect Marketing 75
10.1.3 Marketing Channel Development Trend 77
10.2 Market Positioning 77
10.2.1 Pricing Strategy 77
10.2.2 Brand Strategy 79
10.2.3 Target Client 80
10.3 Distributors/Traders List 80
11 Market Effect Factors Analysis 82
11.1 Technology Progress/Risk 82
11.1.1 Substitutes Threat 82
11.1.2 Technology Progress in Related Industry 82
11.2 Consumer Needs/Customer Preference Change 82
11.3 Economic/Political Environmental Change 82
12 Global Low Molecular Weight Heparin Market Forecast (2018F-2023F) 84
12.1 Global Low Molecular Weight Heparin Capacity, Production, Revenue Forecast (2018F-2023F) 84
12.1.1 Global Low Molecular Weight Heparin Capacity, Production and Growth Rate Forecast (2018-2023) 84
12.1.2 Global Low Molecular Weight Heparin Revenue and Growth Rate Forecast (2018-2023) 85
12.1.3 Global Low Molecular Weight Heparin Price and Trend Forecast (2018-2023) 86
12.2 Global Low Molecular Weight Heparin Production, Consumption, Import and Export Forecast by Regions (2018-2023) 86
12.2.1 USA Low Molecular Weight Heparin Production, Revenue, Consumption, Export and Import Forecast (2018-2023) 86
12.2.2 Europe Low Molecular Weight Heparin Production, Revenue, Consumption, Export and Import Forecast (2018-2023) 87
12.2.3 China Low Molecular Weight Heparin Production, Revenue, Consumption, Export and Import Forecast (2018-2023) 87
12.2.4 Asia (Ex. China) Low Molecular Weight Heparin Production, Revenue, Consumption, Export and Import Forecast (2018-2023) 88
12.3 Global Low Molecular Weight Heparin Production Forecast by Type (2018F-2023F) 88
12.4 Global Low Molecular Weight Heparin Consumption Forecast by Application (2018F-2023F) 88
13 Research Findings and Conclusion 90
14 Appendix 91
Disclosure Section 91
Research Methodology 91
Data Source 92
Disclaimer 93
Author List 94
List of Tables and Figures
Figure Picture of Low Molecular Weight Heparin 1
Figure Global Production Market Share of Low Molecular Weight Heparin by Types in 2016 2
Figure Low Molecular Weight Heparin Consumption Market Share by Applications in 2016 3
Figure USA Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2023) 5
Figure China Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2023) 6
Figure Europe Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2023) 7
Figure Global Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate (2012-2023) 8
Table Global Low Molecular Weight Heparin Capacity (Kg) of Key Manufacturers (2012-2017) 9
Table Global Low Molecular Weight Heparin Capacity Market Share of Key Manufacturers (2012-2017) 9
Figure Global Low Molecular Weight Heparin Capacity Share of Key Manufacturers in 2016 10
Figure Global Low Molecular Weight Heparin Capacity Share of Key Manufacturers in 2017 11
Table Global Low Molecular Weight Heparin Production (Kg) of Key Manufacturers (2012-2017) 11
Table Global Low Molecular Weight Heparin Production Share by Manufacturers (2012-2017) 12
Figure 2016 Low Molecular Weight Heparin Production Share by Manufacturers 13
Figure 2017 Low Molecular Weight Heparin Production Share by Manufacturers 14
Table Global Low Molecular Weight Heparin Revenue (Million USD) by Manufacturers (2012-2017) 14
Table Global Low Molecular Weight Heparin Revenue Share by Manufacturers (2012-2017) 15
Figure 2016 Global Low Molecular Weight Heparin Revenue Share by Manufacturers 16
Figure 2017 Global Low Molecular Weight Heparin Revenue Share by Manufacturers 17
Table Global Market Low Molecular Weight Heparin Average Price (USD/Kg) of Key Manufacturers (2012-2017) 17
Figure Global Market Low Molecular Weight Heparin Average Price (USD/Kg) of Key Manufacturers in 2016 19
Table Manufacturers Low Molecular Weight Heparin Manufacturing Base Distribution 20
Table Manufacturers Low Molecular Weight Heparin Product Types 20
Figure Low Molecular Weight Heparin Market Share of Top 3 Manufacturers 21
Figure Low Molecular Weight Heparin Market Share of Top 5 Manufacturers 22
Table Mergers & Acquisitions, Expansion 22
Table Global Low Molecular Weight Heparin Capacity (Kg) by Regions (2012-2017E) 24
Table Global Low Molecular Weight Heparin Capacity Market Share by Regions (2012-2017E) 24
Figure Global Low Molecular Weight Heparin Capacity Market Share by Regions in 2012-2017 25
Figure 2016 Global Low Molecular Weight Heparin Capacity Market Share by Regions 25
Table Global Low Molecular Weight Heparin Production (Kg) by Regions (2012-2017E) 26
Table Global Low Molecular Weight Heparin Production and Market Share by Regions (2012-2017E) 26
Figure Global Low Molecular Weight Heparin Production Market Share by Regions in 2012-2017 27
Figure 2016 Global Low Molecular Weight Heparin Production Market Share by Regions 27
Table Global Low Molecular Weight Heparin Revenue (Million USD) by Regions (2012-2017E) 28
Table Global Low Molecular Weight Heparin Revenue Market Share by Regions (2012-2017E) 28
Figure 2016 Global Low Molecular Weight Heparin Revenue Market Share by Regions 29
Table Global Low Molecular Weight Heparin Capacity (Kg), Production (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017E) 29
Table USA Low Molecular Weight Heparin Capacity (Kg), Production (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017E) 30
Table Europe Low Molecular Weight Heparin Capacity (Kg), Production (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017E) 30
Table China Low Molecular Weight Heparin Capacity, Capacity (Kg), Production (Kg), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2012-2017E) 31
Table Global Low Molecular Weight Heparin Consumption (Kg) Market by Regions (2012-2017E) 32
Table Global Low Molecular Weight Heparin Consumption Market Share by Regions (2012-2017E) 32
Figure Global Low Molecular Weight Heparin Consumption Market Share by Regions in 2012 33
Figure 2016 Global Low Molecular Weight Heparin Consumption Market Share by Regions 33
Table USA Low Molecular Weight Heparin Production (Kg), Consumption (Kg), Import (Kg) & Export (Kg) (2012-2017E) 34
Table Europe Low Molecular Weight Heparin Production (Kg), Consumption (Kg), Import (Kg) & Export (Kg) (2012-2017E) 34
Table China Low Molecular Weight Heparin Production (Kg), Consumption (Kg), Import (Kg) & Export (Kg) (2012-2017E) 34
Table Asia (Ex. China) Low Molecular Weight Heparin Production (Kg), Consumption (Kg), Import (Kg) & Export (Kg) (2012-2017E) 35
Table Global Low Molecular Weight Heparin Production (Kg) by Types (2012-2017E) 36
Table Global Low Molecular Weight Heparin Production Share by Types (2012-2017E) 36
Figure Production Market Share of Low Molecular Weight Heparin by Types in 2012-2017 37
Figure 2016 Production Market Share of Low Molecular Weight Heparin by Types 37
Table Global Low Molecular Weight Heparin Revenue (Million USD) by Types (2012-2017E) 38
Table Global Low Molecular Weight Heparin Revenue Share by Types (2012-2017E) 38
Figure Production Revenue Share of Low Molecular Weight Heparin by Types in 2012 39
Figure 2016 Revenue Market Share of Low Molecular Weight Heparin by Types 39
Table Global Low Molecular Weight Heparin Price (USD/Kg) by Types (2012-2017E) 40
Figure Global Low Molecular Weight Heparin Production Growth by Type (2012-2017E) 40
Table Global Low Molecular Weight Heparin Consumption (Kg) by Applications (2012-2017E) 41
Table Global Low Molecular Weight Heparin Consumption Market Share by Applications (2012-2017E) 41
Figure Global Low Molecular Weight Heparin Consumption Market Share by Applications in 2016 42
Figure Global Low Molecular Weight Heparin Consumption Growth Rate by Applications (2012-2017E) 43
Table Aspen Profile 44
Table Aspen Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 44
Figure Aspen Low Molecular Weight Heparin Production Market Share (2012 - 2017) 45
Table Sanofi-aventis Profile 46
Table Sanofi-aventis Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 47
Figure Sanofi-aventis Low Molecular Weight Heparin Production Market Share (2012 - 2017) 47
Table Pfizer Profile 48
Table Pfizer Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 48
Figure Pfizer Low Molecular Weight Heparin Production Market Share (2012 - 2017) 49
Table Opocrin Profile 50
Table Opocrin Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 50
Figure Opocrin Low Molecular Weight Heparin Production Market Share (2012 - 2017) 51
Table CSBIO Profile 51
Table Specification of CSBIO Product 52
Table CSBIO Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 53
Figure CSBIO Low Molecular Weight Heparin Production Market Share (2012 - 2017) 53
Table Dongying Tiandong Pharmaceutical Profile 54
Table Picture of Dongying Tiandong Pharmaceutical 54
Table Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 55
Figure Dongying Tiandong Pharmaceutical Low Molecular Weight Heparin Production Market Share (2012 - 2017) 56
Table Changzhou Qianhong Bio-pharma Profile 56
Figure Low Molecular Weight Heparin Picture of Changzhou Qianhong Bio-pharma 57
Table Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 57
Figure Changzhou Qianhong Bio-pharma Low Molecular Weight Heparin Production Market Share (2012 - 2017) 58
Table Techdow Profile 58
Table Low Molecular Weight Heparin Product Information 59
Table Techdow Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 60
Figure Techdow Low Molecular Weight Heparin Production Market Share (2012 - 2017) 61
Table Yantai Dongcheng Pharmaceutical Group Profile 61
Table Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Capacity, Production, Revenue, Price and Gross Margin (2012 - 2017) 62
Figure Yantai Dongcheng Pharmaceutical Group Low Molecular Weight Heparin Production Market Share (2012 - 2017) 63
Table Key Suppliers of Raw Materials 64
Figure Manufacturing Cost Structure of Low Molecular Weight Heparin 65
Figure US Average Hourly Wages (USD/Hour) in Manufacturing 66
Figure Germany Average Hourly Wages in Manufacturing Index 66
Figure UK Average Weekly Wages (GBP/Week) in Manufacturing 67
Figure China Average Yearly Wages (CNY/Year) in Manufacturing 67
Figure Asia (Ex. China) Average Monthly Wages (JPY Thousand/Month) in Manufacturing 68
Figure South Korea Total Monthly Wages (KRW /Month) in Manufacturing 68
Figure Australia Average (AUD/Week) Week Wages in Manufacturing 69
Figure New Zealand Average Hourly Wages (NZD/Hour) 69
Figure Manufacturing Process Analysis of Low Molecular Weight Heparin 70
Figure Low Molecular Weight Heparin Industrial Chain Analysis 71
Table Raw Materials Sources of Low Molecular Weight Heparin Major Manufacturers in 2016 72
Table Major Buyers of Low Molecular Weight Heparin 72
Figure Marketing Channel Status in 2016 77
Table Distributors/Traders List 80
Figure Global Low Molecular Weight Heparin Capacity (Kg), Production (Kg) and Growth Rate Forecast (2018F-2023F) 84
Figure Global Low Molecular Weight Heparin Revenue (Million USD) and Growth Rate Forecast (2018F-2023F) 85
Figure Global Low Molecular Weight Heparin Price (USD/Kg) and Trend Forecast (2018-2023) 86
Table USA Low Molecular Weight Heparin Production, Revenue, Consumption, Export and Import Forecast (2018-2023) 86
Table Europe Low Molecular Weight Heparin Production, Revenue, Consumption, Export and Import Forecast (2018-2023) 87
Table China Low Molecular Weight Heparin Production, Revenue, Consumption, Export and Import Forecast (2018-2023) 87
Table Asia (Ex. China) Low Molecular Weight Heparin Production, Revenue, Consumption, Export and Import Forecast (2018-2023) 88
Table Global Low Molecular Weight Heparin Production (Kg) Forecast by Type (2018F-2023F) 88
Table Global Low Molecular Weight Heparin Consumption (Kg) Forecast by Application (2018F-2023F) 88
  • Global and China Heparin Sodium Market Research by Company, Type & Application 2013-2025
    Published: 16-Nov-2017        Price: US 2000 Onwards        Pages: 105
    Summary Market Segment as follows: By Type - Type 1 - Type 2 - Type 3 By Application - Treatment of Venous Thromboembolism - Complications of Pregnancy - Cardioversion of Atrial Fibrillation/Flutter By Company - Shenzhen Hepalink - Bioibérica - Nanjing King-friend - Pfizer - SPL - Dongcheng Biochemicals - Changzhou Qianhong Bio-pharma - Cha......
  • Global Heparin Industry 2017 Market Research Report
    Published: 13-Nov-2017        Price: US 2900 Onwards        Pages: 147
    This report studies the Heparin market status and outlook of global and major regions, from angles of players, regions, product types and end industries; this report analyzes the top players in global and major regions, and splits the Heparin market by product type and applications/end industries. In the last several years, Global market of Heparin developed rapidly, with an average growth rate of 3.3%. In 2016, Global Revenue of Heparin is nearly 910 M USD; the actual production ......
  • Global Heparin Sodium Market Research Report 2017
    Published: 10-Nov-2017        Price: US 2900 Onwards        Pages: 141
    With increasing downstream demand, global heparin sodium API production also increased from 90768 Kg in 2007 to 138099 Kg in 2012. In 2007, the global market of heparin sodium was valued at 222 million USD. From 2007 to 2012, as the price of heparin sodium increasing, global heparin sodium market has grown fivefold in market size. Over the past five years, the price of global heparin sodium has been declining. At present, the global heparin sodium market size is about 700 million USD. Global hep......
  • Global Intravenous Immunoglobulin (IVIg) Market Research Report 2017
    Published: 09-Nov-2017        Price: US 2900 Onwards        Pages: 110
    In this report, the global Intravenous Immunoglobulin (IVIg) market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Intravenous Immunoglobulin (IVIg) in these regions, from 2012 to 2022 (forecast), covering - North America ......
  • Global and Regional Injectable Anticoagulants Market Research Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 122
    Summary The injectable anticoagulants include low molecular weight heparin (LMWH) agents (dalteparin [Fragmin?], enoxaparin [Lovenox?]) and factor Xa inhibitors (fondaparinux [Arixtra?]).In general, the injectable anticoagulants are Food and Drug Administration (FDA)-approved for prophylaxis and/or treatment of venous thromboembolism. Market Segment as follows: By Region - Asia-Pacific - North America - Europe - South Ameri......
  • Global and Regional Anticoagulants Market Research Report 2017
    Published: 09-Nov-2017        Price: US 3500 Onwards        Pages: 155
    Summary Anticoagulants, commonly referred to as blood thinners, are substances that prevent or reduce coagulation of blood, prolonging the clotting time. Some of them occur naturally in blood-eating animals such as leeches and mosquitoes, where they help keep the bite area unclotted long enough for the animal to obtain some blood. As a class of medications, anticoagulants are used in therapy for thrombotic disorders. Oral anticoagulants (OACs) are taken by many people in pill or t......
  • North America Fibrinogen Concentrates Market by Manufacturers, Countries, Type and Application, Forecast to 2022
    Published: 09-Nov-2017        Price: US 4480 Onwards        Pages: 123
    Fibrinogen (factor I) is a glycoprotein in vertebrates that helps in the formation of blood clots. Fibrinogen Concentrate is used as a medicine for blood disease. Fibrinogen concentrate is a preparation of coagulation factors prepared from pooled plasma. Currently, only RiaSTAP (CSL Behring) is licensed in a number of countries for multiple indications including treating acute bleeding episodes with Hypofibrinogenemia. Other manufacturer's product are justly used in local region or countries.......
  • Global Injectable Anticoagulants Market Research Report 2017
    Published: 08-Nov-2017        Price: US 2900 Onwards        Pages: 106
    In this report, the global Injectable Anticoagulants market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022. Geographically, this report is segmented into several key Regions, with production, consumption, revenue (million USD), market share and growth rate of Injectable Anticoagulants in these regions, from 2012 to 2022 (forecast), covering - North America - Europe ......
  • Asia-Pacific Heparin Sodium Market by Manufacturers, Regions, Type and Application, Forecast to 2022
    Published: 08-Nov-2017        Price: US 4480 Onwards        Pages: 120
    Heparin sodium is an anticoagulant (blood thinner) that prevents the formation of blood clots. Heparin is used to treat and prevent blood clots in the veins, arteries, or lung. It is also used before surgery to reduce the risk of blood clots. Scope of the Report: This report focuses on the Heparin Sodium in Asia-Pacific market, especially in China, Japan, Korea, Taiwan, Southeast Asia, India and Australia. This report categorizes the market based on manufacturers, countries......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs